anesthesia glp-1 news Glucagon-Like Peptide 1 Receptor Agonists and Aspiration Risk Glucagon-Like Peptide-1 Receptor Agonists in

It progresses silently, often detected only when significant damage has already occurred

Compounding rules have also tightened in 2026, so availability can change

Additionally, species-specific variations in GLP-1 receptor structure and expression complicate direct extrapolation across preclinical models, thereby increasing uncertainty in cross-system interpretation

Most protocols recommend restarting at the initial dose or one step below your previous dose and re-escalating

doi: 10.14309/ajg.0000000000002564

When your profits come from keeping people on a weight management drug long-term, theres little incentive to warn patients adequately about permanent stomach paralysis or sudden vision loss